Nyumbani › Saratanii za Damu › Oklahoma
Majaribio ya kliniki ya Saratanii za Damu katika jimbo la Oklahoma
Masomo 8 ya Saratanii za Damu yanatafuta washiriki katika vituo vya jimbo la Oklahoma.
Miji katika jimbo la Oklahoma
Maandishi rasmi ya utafiti (Kiingereza)
Long-term Safety and Efficacy Extension Study for Participants With Advanced Tumors Who Are Currently on Treatment or in Follow-up in a Pembrolizumab (MK-3475) Study (MK-3475-587/KEYNOTE-587)
- Oklahoma Cancer Specialists and Research Institute, LLC ( Site 0082), Tulsa
InaajiriHatua 3
Umri 18 na zaidi · Jinsia zote · Imesasishwa 2 Okt 2026 · NCT03486873Collecting Blood Samples From Patients With and Without Cancer to Evaluate Tests for Early Cancer Detection
- Mercy Hospital Oklahoma City, Oklahoma City
InaajiriUtafiti wa uchunguziWajitolea wenye afya wanakaribishwa
Umri 40 hadi 75 · Jinsia zote · Imesasishwa 2 Okt 2026 · NCT05334069Collection of Research Data and Samples From Patients Treated With Immunotherapy to Study Its Side Effects
- Mercy Hospital Oklahoma City, Oklahoma City
InaajiriUtafiti wa uchunguzi
Umri wote · Jinsia zote · Imesasishwa 17 Sep 2026 · NCT04242095Safety and Tolerability of Ziftomenib Combinations in Patients With Relapsed/Refractory Acute Myeloid Leukemia
- OU Health Stephenson Cancer Center, Oklahoma City
InaajiriHatua 1
Umri 18 na zaidi · Jinsia zote · Imesasishwa 20 Ago 2026 · NCT06001788PUL-042 Treatment in Patients With Parainfluenza Virus (PIV), Human Metapneumovirus (hMPV) or Respiratory Syncytial Virus (RSV)
- OU Health Physicians - Infectious Disease Clinic, Oklahoma City
InaajiriHatua 2
Umri 18 na zaidi · Jinsia zote · Imesasishwa 4 Ago 2026 · NCT06665100A Multicenter Access and Distribution Protocol for Unlicensed Cryopreserved Cord Blood Units (CBUs)
- University of Oklahoma Health Science Center, Oklahoma City
InaajiriUtafiti wa uchunguzi
Umri wote · Jinsia zote · Imesasishwa 6 Jul 2026 · NCT01351545A Study of the Drug Letermovir as Prevention of Cytomegalovirus Infection After Stem Cell Transplant in Pediatric Patients
- University of Oklahoma Health Sciences Center, Oklahoma City
InaajiriHatua 3
Umri 2 hadi 18 · Jinsia zote · Imesasishwa 5 Mei 2026 · NCT05711667A Study to Investigate the Safety and Tolerability of Ziftomenib in Combination With Venetoclax/Azacitidine, Venetoclax, 7+3, or 7+3+Quizartinib in Patients With AML
- OU Health Stephenson Cancer Center, Oklahoma City
InaajiriHatua 1
Umri 18 na zaidi · Jinsia zote · Imesasishwa 13 Mac 2026 · NCT05735184Kutoka ClinicalTrials.gov, data iliyopatikana 5 Okt 2026. Kila utafiti una masharti yake ya kufaa; timu ya utafiti huamua nani anaweza kujiunga.